avonex - interferon beta-1a
(Interferon Beta-1a)Biogen Inc.
Usage: AVONEX treats relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Biogen Inc. drugs
9 results
byooviz - ranibizumab - nuna injection, solution
(Ranibizumab-Nuna)Biogen Inc.Usage: Byooviz treats neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV).opuviz
(Aflibercept-Yszy)Biogen Inc.plegridy - peginterferon beta-1a injection, solution
(Peginterferon Beta-1a)Biogen Inc.Usage: Plegridy treats relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.qalsody - tofersen injection
(Tofersen)Biogen Inc.Usage: Qalsody treats ALS (amyotrophic lateral sclerosis) in adults with a SOD1 gene mutation. Approved under accelerated approval based on reduction in plasma neurofilament light chain; continued approval may depend on confirmatory trial results.spinraza - nusinersen injection, solution
(Nusinersen)Biogen Inc.Usage: SPINRAZA treats spinal muscular atrophy (SMA) in pediatric and adult patients.tecfidera - dimethyl fumarate
(Dimethyl Fumarate)Biogen Inc.Usage: Tecfidera treats relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.tysabri - natalizumab injection
(Natalizumab)Biogen Inc.Usage: TYSABRI treats relapsing forms of multiple sclerosis (clinically isolated syndrome, relapsing-remitting, and active secondary progressive disease) in adults, and induces and maintains remission in adults with moderately to severely active Crohn's disease unresponsive to conventional therapies or TNF-α inhibitors.vumerity - diroximel fumarate capsule
(Diroximel Fumarate)Biogen Inc.Usage: Vumerity treats relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.